HL
Healios K.K.
HLOSF · OTC
$2.70 +50.00% (+$0.90)
Market Cap ¥37.9B
P/E Ratio 204.88x
Div. Yield -
ROE 3.06%
Piotroski F-Score Moderate
4/9Valuation
12 /100
Expensive P/S 639.98x
P/B 4.36x
P/E 204.88x
Growth
45 /100
Stable Book val. growth 3.75%
Rev. growth 4.97%
FCF growth N/A
Profitability
20 /100
Weak Net margin 312.37%
Op. margin 7,091.59%
FCF margin 7,414.54%
Quality
5 /100
Poor ROE 3.06%
ROA 0.81%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 2.37x
Int. coverage -1.07x
Debt/Equity 0.29x
Stability
36 /100
Moderate Rev. volatility 230.43%
EPS volatility 21.30%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HLOSF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tadahisa S. Kagimoto
Employees
75
Headquarters
Tokyo
Upcoming events
18 NOV
Earnings
Upcoming earnings report